Altium International is proud to partner with Innopsys, a pioneering French company founded in 1999, that develops, manufactures, and supports advanced imaging equipment for life science and medical research laboratories worldwide.With headquarters and production in Carbonne, France, Innopsys combines precision engineering with innovation across optics, micromechanics, electronics, computing, and biology. Over 60% of its workforce are scientists and engineers, driving forward a strategy of continual innovation with more than 30% of annual turnover invested in R&D. This dedication has resulted in numerous international patents and strong collaborations with both academic and industrial partners.Key solutions include:InnoScan® Microarray Scanners – a complete range of high-performance microarray readers, setting the standard since 2006.InnoQuant® Fluorescence Scanner – launched in 2023, a breakthrough line-scanning system for tissue multiplexing, histotechnology, and immunocytochemistry that eliminates tiling and stitching issues common in fluorescence imaging.All Innopsys products are designed and manufactured under ISO 13485 certification, ensuring rigorous quality standards for biomedical applications. Every instrument undergoes extensive stability and reliability testing before delivery.Sustainability is also integral to Innopsys. Their eco-designed facility follows high environmental quality principles, and in 2024, the company was awarded an EcoVadis Silver Medal for corporate social responsibility, placing them among the top-performing companies worldwide in ethical practices and environmental stewardship.Today, Innopsys instruments are distributed in more than 50 countries, supported by a global network of partners and a dedicated U.S. subsidiary in Chicago. Their customer support teams, together with local partners like Altium International, ensure responsive service, training, and remote diagnostic capabilities worldwide.By bringing Innopsys technologies to our customers, Altium International helps researchers expand possibilities in multiplex imaging, microarray analysis, biosensor development, and single-cell studies, enabling the breakthroughs of tomorrow.If you are interested in Innopsys technologies or products, please contact us at info.us@altium.net for more information.